Internal Medicine · Hemet, CA
NPI
1669552485
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1278 E Latham Ave
Hemet, CA, 92543
Phone (951) 925-6625
Groups this clinician bills Medicare through
Medicare paid, 2024
$411K
27,727 services
Medicare patients, 2024
485
Average age 74
Drug cost, 2024
$4.8M
32,934 prescriptions
Company payments, 2025
$2,549
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hemchand Kolli was code 99213 (office e&m - established), 2,583 times for 439 patients. In total Hemchand Kolli billed 27,727 services in 53 codes, and Medicare paid $411K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,583 | 439 | $65.49 | $169K |
| 96372 Injection Administration | Office | 1,022 | 173 | $11.12 | $11K |
| 99214 Office E&M - Established | Office | 814 | 295 | $97.49 | $79K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 565 | 130 | $0.94 | $528 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 518 | 64 | $0.33 | $173 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 493 | 65 | $0.76 | $377 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 340 | 49 | $0.08 | $28.28 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 258 | 258 | $133.24 | $34K |
| G0008 Administration of influenza virus vaccine | Office | 182 | 172 | $33.36 | $6,072 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 160 | 160 | $19.78 | $3,165 |
| 90661 Vaccine Product | Office | 157 | 155 | $36.11 | $5,669 |
| 99497 Care Management/Coordination | Office | 152 | 146 | $65.08 | $9,892 |
| 90677 Vaccine Product | Office | 97 | 94 | $289.43 | $28K |
| G0009 Administration of pneumococcal vaccine | Office | 94 | 91 | $33.36 | $3,136 |
| 93000 Electrocardiogram | Office | 92 | 78 | $10.36 | $953 |
By year: 2022 $600K for 20,804 services; 2023 $363K for 20,908 services; 2024 $411K for 27,727 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 89 | 63 | $3.21 | $286 |
| 36415 Venipuncture Blood Collection | 67 | 11 | $8.65 | $580 |
Medicare prescription drug claims, 2024
In 2024, the drug Hemchand Kolli prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,909 prescriptions and refills. In total Hemchand Kolli wrote 32,934 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,909 | 4,825 | 538 | $22K |
| Levothyroxine Sodium Generic | 984 | 2,341 | 236 | $11K |
| Losartan Potassium Generic | 937 | 2,478 | 281 | $9,731 |
| Gabapentin Generic | 876 | 1,517 | 204 | $15K |
| Amlodipine Besylate Generic | 751 | 1,917 | 226 | $5,111 |
| Famotidine Generic | 651 | 1,359 | 176 | $8,925 |
| Lisinopril Generic | 602 | 1,451 | 180 | $4,502 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 583 | 646 | 160 | $22K |
| Omeprazole Generic | 557 | 1,243 | 165 | $7,906 |
| Metformin Hcl Generic | 554 | 1,414 | 171 | $5,479 |
| Tamsulosin Hcl Generic | 538 | 1,246 | 153 | $8,718 |
| Metoprolol Succinate Generic | 509 | 1,348 | 153 | $7,022 |
| Pantoprazole Sodium Generic | 494 | 1,166 | 144 | $9,588 |
| Furosemide Generic | 447 | 849 | 136 | $2,763 |
| Jardiance Empagliflozin | 439 | 780 | 101 | $429K |
Brand drugs: 5,999 claims; generic drugs: 26,549 claims; opioid claims: 860.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hemchand Kolli $2,549 ($2,549 in general payments such as food, travel and fees) from 32 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $311.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $311 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $284 |
| Novo Nordisk Inc NVO | 16 | $230 |
| GlaxoSmithKline, LLC. GSK | 10 | $200 |
| Amgen Inc. AMGN | 23 | $158 |
| Janssen Biotech, Inc. JNJ | 1 | $150 |
| Lilly USA, LLC LLY | 11 | $146 |
| Merck Sharp & Dohme LLC MRK | 5 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $78.92 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $78.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.